Los Angeles Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,725
Closed -$213K 1320
2016
Q2
$213K Sell
2,725
-3,820
-58% -$272K ﹤0.01% 1144
2016
Q1
$360K Buy
+6,545
New +$357K ﹤0.01% 918
2015
Q4
Sell
-3,200
Closed -$202K 1222
2015
Q3
$202K Hold
3,200
﹤0.01% 1108
2015
Q2
$234K Sell
3,200
-1,502
-32% -$109K ﹤0.01% 1117
2015
Q1
$308K Sell
4,702
-408
-8% -$27.1K ﹤0.01% 1052
2014
Q4
$332K Buy
5,110
+340
+7% +$21.9K ﹤0.01% 940
2014
Q3
$287K Sell
4,770
-7,974
-63% -$521K ﹤0.01% 930
2014
Q2
$883K Buy
12,744
+9,369
+278% +$607K 0.01% 713
2014
Q1
$221K Buy
+3,375
New +$220K ﹤0.01% 1160

Other funds holding STJ

Los Angeles Capital Management's STJ Position: Q3 2016 in Review

Los Angeles Capital Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 2,725 shares — an estimated $213K sold.

Los Angeles Capital Management first reported a position in STJ in Q1 2014 and held it in 9 quarters. The position peaked at $883K in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Los Angeles Capital Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Los Angeles Capital Management sold 2,725 St Jude Medical shares in Q3 2016, an estimated $213K.
  • Los Angeles Capital Management first reported a position in St Jude Medical in Q1 2014 and held it in 9 quarters.
  • Los Angeles Capital Management's St Jude Medical position peaked at $883K in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Los Angeles Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.